Menu
Menu
We’re a passionate team of scientists and engineers driven by a single mission.
Chief Executive Officer
Sian graduated from Ulster University with a first-class honours degree in Master of Pharmacy (MPharm) in 2015. She has received numerous prestigious awards, including The Randox Award for Biomolecular Immunology and Therapeutics, The Sir Allen McClay Award for the Best Science Project, and The Royal Pharmaceutical Award for the most outstanding MPharm student. Sian honed her clinical skills in oncology at Bristol Royal Infirmary and was the Regional Pre-Registration Winner for the South West of England. She returned to Ulster University for a PhD, developing advanced sonodynamic therapy nanoparticles for pancreatic cancer. In 2021, she co-founded StimOxyGen, leading it to win the INVENT 2021 awards across three categories. Recognised in Belfast Telegraph’s "30 under 30" entrepreneurs in Northern Ireland and on the MIT Technology Review’s Under 35 Europe 2022 list, Sian is responsible for strategic leadership, operational, financial and risk management, communication, stakeholder engagement, and performance monitoring at StimOxyGen.
Chief Scientific Officer
Anthony is a Professor of Medical Biotechnology at Ulster University with over 20 years of experience in stimulus-responsive drug/gene delivery systems for oncology and tissue regeneration. He has authored over 130 peer-reviewed publications and patents and has received research funding from the EU, EPSRC, InvestNI, CRUK, PCRF, and PCUK. As a founder of Gendel Limited and SonoTarg Ltd., Tony has secured commercial funding from various sources. He is one of the inventors of the StimOxyGen technology and contributes to the project by advising on technological development, safety studies, in vivo studies, and model development.
Business Advisor
With more than 40 years of experience in the medical devices and biopharmaceutical industries, Les was the founding CEO and Chairman of OrganOx Limited, where he led the company from laboratory bench to full commercialisation. He has extensive experience in R&D and Business Development and has successfully led the development of several products from bench stage to full commercial sale. Les holds 1st Class Honours and PhD degrees in Chemistry from the University of London. At StimOxyGen, Les is involved in strategic planning, commercial exploitation, and stakeholder engagement.
R&D Scientist
Tierna graduated with a BSci in Biology from Ulster University in 2020 and pursued a PhD investigating the development of oxygen-generating nanoparticles for wound healing. She has extensive experience in formulation science and pre-clinical efficacy testing using 2D/3D cell and murine models of wound healing and oncology. Tierna obtained her NILTG PILB license in 2023 and has experience in preclinical oncology models.
Chairperson
Sam is an accomplished entrepreneur with over 15 years of experience in pharmaceutical development, specialising in oncology, immunology, and materials science. As CEO and cofounder of Duo Oncology Inc., he leads the development of innovative cancer therapies. Sam has a proven track record of raising significant funding and has extensive experience in building and leading interdisciplinary teams. He holds a Ph.D. in Chemical Engineering from the University of Pittsburgh and a B.S. in Chemical Engineering with a minor in Biomedical Engineering from Bucknell University. Sam is passionate about developing exceptional and economical therapies for patients with significant unmet medical needs.
Subscribe to our mailing list to stay up to date
© 2024 StimOxyGen
Registered in Northern Ireland: NI677236
